These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 29960237)
1. Chemometrics-assisted study of the interconversion between the crystalline forms of nimodipine. Calvo NL; Balzaretti NM; Antonio M; Kaufman TS; Maggio RM J Pharm Biomed Anal; 2018 Sep; 158():461-470. PubMed ID: 29960237 [TBL] [Abstract][Full Text] [Related]
2. A dynamic thermal ATR-FTIR/chemometric approach to the analysis of polymorphic interconversions. Cimetidine as a model drug. Calvo NL; Maggio RM; Kaufman TS J Pharm Biomed Anal; 2014 Apr; 92():90-7. PubMed ID: 24509287 [TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approach. Rahman Z; Siddiqui A; Khan MA Int J Pharm; 2013 Oct; 455(1-2):113-23. PubMed ID: 23911342 [TBL] [Abstract][Full Text] [Related]
4. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage. Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761 [TBL] [Abstract][Full Text] [Related]
5. Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs. Siddiqui A; Rahman Z; Sayeed VA; Khan MA J Pharm Sci; 2013 Nov; 102(11):4024-35. PubMed ID: 23963767 [TBL] [Abstract][Full Text] [Related]
6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization of nimodipine-polyethylene glycol solid dispersion systems. Barmpalexis P; Kachrimanis K; Georgarakis E Drug Dev Ind Pharm; 2014 Jul; 40(7):886-95. PubMed ID: 23611475 [TBL] [Abstract][Full Text] [Related]
8. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Urbanetz NA Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995 [TBL] [Abstract][Full Text] [Related]
9. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545 [TBL] [Abstract][Full Text] [Related]
10. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Yi T; Wan J; Xu H; Yang X Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418 [TBL] [Abstract][Full Text] [Related]
11. Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment. Calvo NL; Kaufman TS; Maggio RM J Pharm Biomed Anal; 2016 Apr; 122():157-65. PubMed ID: 26874854 [TBL] [Abstract][Full Text] [Related]
12. At-line green synthesis monitoring of new pharmaceutical co-crystals lamivudine:theophylline polymorph I and II, quantification of polymorph I among its APIs using FT-IR spectroscopy and MCR-ALS. Mazivila SJ; Castro RAE; Leitão JMM; Esteves da Silva JCG J Pharm Biomed Anal; 2019 May; 169():235-244. PubMed ID: 30877935 [TBL] [Abstract][Full Text] [Related]
13. Phase transformations of amlodipine besylate solid forms. Koradia V; de Lemos AF; Allesø M; de Diego HL; Ringkjøbing-Elema M; Müllertz A; Rantanen J J Pharm Sci; 2011 Jul; 100(7):2896-910. PubMed ID: 21344410 [